The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Highlights from IMW 2019 Part I
Francesca Gay and Katja Weisel
• 25 Sep 2019
Katja Weisel, MD, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, and Francesca Gay, MD, University of Turin, Turin, Italy, discuss highlights from the International Myeloma Workshop (IMW) 2019, held in Boston, MA, with particular focus on the CASSIOPEIA trial (NCT02541383) and the future of measurable residual disease (MRD) in myeloma treatment.
